CAPO Publications

Data from CAPO has been used in numerous publications for more than a decade. This list represents a sampling. All of them can be found on PubMed (PubMed document identifiers are provided).

  1. Adults Hospitalized with Pneumonia in the United States: Incidence, Epidemiology & Mortality. Ramirez JA Wiemken TL Peyrani P Arnold FW Kelley R Mattingly WA Nakamatsu R Pena S Guinn BE Furmanek SP Persaud AK Raghuram A Fernandez F Beavin L Bosson R Fernandez-Botran R Cavallazzi R Bordon J Valdivieso C Schulte J Carrico RM University of Louisville Pneumonia Study Group. . Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  2017 Jul 28  ()  . PubMed ID: 29020164
  2. Acute Low-Dose Hydralazine-Induced Lupus Pneumonitis. Holman SK Parris D Meyers S Ramirez J . Case reports in pulmonology  2017  2017 ()  2650142. PubMed ID: 28932614
  3. Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study. Aliberti S Morlacchi LC Faverio P Fernandez-Botran R Cosentini R Mantero M Peyrani P Ramirez J Bordon J Blasi F . Pneumonia (Nathan Qld.)  2016  8 ()  8. PubMed ID: 28702287
  4. The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization. Peyrani P Wiemken TL Metersky ML Arnold FW Mattingly WA Feldman C Cavallazzi R Fernandez-Botran R Bordon J Ramirez JA . Infectious diseases (London, England)  2017 Jul 12  ()  1-8. PubMed ID: 28699429
  5. Individualizing duration of antibiotic therapy in community-acquired pneumonia. Aliberti S Ramirez J Giuliani F Wiemken T Sotgiu G Tedeschi S Carugati M Valenti V Marchioni M Camera M Piro R Del Forno M Milani G Faverio P Richeldi L Deotto M Villani M Voza A Tobaldini E Bernardi M Bellone A Bassetti M Blasi F . Pulmonary pharmacology & therapeutics  2017 Aug  45 ()  191-201. PubMed ID: 28666965
  6. Long-term Mortality in Hospitalized Patients With Community-Acquired Pneumonia. Peyrani P Ramirez J . The American journal of the medical sciences  2017 May  353 (5)  421. PubMed ID: 28502325
  7. Using cluster analysis of cytokines to identify patterns of inflammation in hospitalized patients with community-acquired pneumonia: a pilot study. Wiemken TL Kelley RR Fernandez-Botran R Mattingly WA Arnold FW Furmanek SP Restrepo MI Chalmers JD Peyrani P Cavallazzi R Bordon J Aliberti S Ramirez JA . The University of Louisville journal of respiratory infections  2017  1 (1)  3-11. PubMed ID: 28393141
  8. Neutrophils and Ly6Chi monocytes collaborate in generating an optimal cytokine response that protects against pulmonary Legionella pneumophila infection. Casson CN Doerner JL Copenhaver AM Ramirez J Holmgren AM Boyer MA Siddarthan IJ Rouhanifard SH Raj A Shin S . PLoS pathogens  2017 Apr  13 (4)  e1006309. PubMed ID: 28384349
  9. Role of Atypical Pathogens in the Etiology of Community-Acquired Pneumonia. Arnold FW Summersgill JT Ramirez JA . Seminars in respiratory and critical care medicine  2016 Dec  37 (6)  819-828. PubMed ID: 27960206
  10. Comparing posteroanterior with lateral and anteroposterior chest radiography in the initial detection of parapneumonic effusions. Moffett BK Panchabhai TS Nakamatsu R Arnold FW Peyrani P Wiemken T Guardiola J Ramirez JA . The American journal of emergency medicine  2016 Dec  34 (12)  2402-2407. PubMed ID: 27793503
  11. Acute myocardial infarction <i>versus</i> other cardiovascular events in community-acquired pneumonia. Aliberti S Ramirez J Cosentini R Valenti V Voza A Rossi P Stolz D Legnani D Pesci A Richeldi L Peyrani P Massari FM Blasi F . ERJ open research  2015 May  1 (1)  . PubMed ID: 27730139
  12. A novel excitatory network for the control of breathing. Anderson TM Garcia AJ 3rd Baertsch NA Pollak J Bloom JC Wei AD Rai KG Ramirez JM . Nature  2016 Aug 4  536 (7614)  76-80. PubMed ID: 27462817
  13. The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia. Luna CM Palma I Niederman MS Membriani E Giovini V Wiemken TL Peyrani P Ramirez J . Annals of the American Thoracic Society  2016 Sep  13 (9)  1519-26. PubMed ID: 27398827
  14. Viral infection in community-acquired pneumonia: a systematic review and meta-analysis. Burk M El-Kersh K Saad M Wiemken T Ramirez J Cavallazzi R . European respiratory review : an official journal of the European Respiratory Society  2016 Jun  25 (140)  178-88. PubMed ID: 27246595
  15. Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia. Egger ME Myers JA Arnold FW Pass LA Ramirez JA Brock GN . BMC medical informatics and decision making  2016 Mar 15  16 ()  34. PubMed ID: 26976388
  16. Real-Time Enrollment Dashboard For Multisite Clinical Trials. Mattingly WA Kelley RR Wiemken TL Chariker JH Peyrani P Guinn BE Binford LE Buckner K Ramirez J . Contemporary clinical trials communications  2015 Oct 30  1 ()  17-21. PubMed ID: 26878068
  17. Auscultation of Velcro Crackles is Associated With Usual Interstitial Pneumonia. Sellarés J Hernández-González F Lucena CM Paradela M Brito-Zerón P Prieto-González S Benegas M Cuerpo S Espinosa G Ramírez J Sánchez M Xaubet A . Medicine  2016 Feb  95 (5)  e2573. PubMed ID: 26844464
  18. Macrolide Use and Neutrophil Function/Cytokine Levels in Hospitalized Patients with Community-Acquired Pneumonia: A Pilot Study. Arnold FW Bordon J Fernandez-Botran R Rane MJ Uriarte SM Kelley R Wiemken TL Peyrani P Ramirez JA Community-Acquired Pneumonia Inflammatory Study Group. . Lung  2016 Feb  194 (1)  155-62. PubMed ID: 26553025
  19. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response. Bordon JM Fernandez-Botran R Wiemken TL Peyrani P Uriarte SM Arnold FW Rodriquez-Hernandez L Rane MJ Kelley RR Binford LE Uppatla S Cavallazzi R Blasi F Aliberti S Restrepo MI Fazeli S Mathur A Rahmani M Ayesu K Ramirez J . Infection  2015 Dec  43 (6)  729-38. PubMed ID: 26424683
  20. De-escalation therapy among bacteraemic patients with community-acquired pneumonia. Carugati M Franzetti F Wiemken T Kelley RR Peyrani P Blasi F Ramirez J Aliberti S . Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases  2015 Oct  21 (10)  936.e11-8. PubMed ID: 26115864
  21. Outcomes in patients with community-acquired pneumonia admitted to the intensive care unit. Cavallazzi R Wiemken T Arnold FW Luna CM Bordon J Kelley R Feldman C Chalmers JD Torres A Ramirez J . Respiratory medicine  2015 Jun  109 (6)  743-50. PubMed ID: 25956021
  22. Endotracheal tube biofilm translocation in the lateral Trendelenburg position. Li Bassi G Fernandez-Barat L Saucedo L Giunta V Marti JD Tavares Ranzani O Aguilera Xiol E Rigol M Roca I Muñoz L Luque N Esperatti M Saco MA Ramirez J Vila J Ferrer M Torres A . Critical care (London, England)  2015 Feb 27  19 ()  59. PubMed ID: 25887536
  23. How to choose the duration of antibiotic therapy in patients with pneumonia. Aliberti S Giuliani F Ramirez J Blasi F DURATION Study Group. . Current opinion in infectious diseases  2015 Apr  28 (2)  177-84. PubMed ID: 25692271
  24. What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia? Peyrani P Ramirez J . Current opinion in infectious diseases  2015 Apr  28 (2)  164-70. PubMed ID: 25692268
  25. Midregional proadrenomedullin for prognosis in community-acquired pneumonia: a systematic review. Cavallazzi R El-Kersh K Abu-Atherah E Singh S Loke YK Wiemken T Ramirez J . Respiratory medicine  2014 Nov  108 (11)  1569-80. PubMed ID: 25448309
  26. Characteristics associated with clinician diagnosis of aspiration pneumonia: a descriptive study of afflicted patients and their outcomes. Lanspa MJ Peyrani P Wiemken T Wilson EL Ramirez JA Dean NC . Journal of hospital medicine  2015 Feb  10 (2)  90-6. PubMed ID: 25363892
  27. Gravity predominates over ventilatory pattern in the prevention of ventilator-associated pneumonia. Li Bassi G Marti JD Saucedo L Rigol M Roca I Cabanas M Muñoz L Ranzani OT Giunta V Luque N Esperatti M Gabarrus A Fernandez L Rinaudo M Ferrer M Ramirez J Vila J Torres A . Critical care medicine  2014 Sep  42 (9)  e620-7. PubMed ID: 24979484
  28. Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study. Peyrani P Wiemken TL Kelley R Zervos MJ Kett DH File TM Jr Stein GE Ford KD Scerpella EG Welch V Ramirez JA IMPACT-HAP Study Group. . Critical care (London, England)  2014 Jun 10  18 (3)  R118. PubMed ID: 24916853
  29. Ruling out Legionella in community-acquired pneumonia. Haubitz S Hitz F Graedel L Batschwaroff M Wiemken TL Peyrani P Ramirez JA Fux CA Mueller B Schuetz P . The American journal of medicine  2014 Oct  127 (10)  1010.e11-9. PubMed ID: 24813862
  30. Adherence with national guidelines in hospitalized patients with community-acquired pneumonia: results from the CAPO study in Venezuela. Levy G Perez M Rodríguez B Hernández Voth A Perez J Gnoni M Kelley R Wiemken T Ramirez J . Archivos de bronconeumologia  2015 Apr  51 (4)  163-8. PubMed ID: 24809678
  31. Risk factors for pulmonary tuberculosis in community-acquired pneumonia. Cavallazzi R Wiemken T Ramirez J . The European respiratory journal  2014 Apr  43 (4)  1214. PubMed ID: 24687677
  32. Cardiac diseases complicating community-acquired pneumonia. Aliberti S Ramirez JA . Current opinion in infectious diseases  2014 Jun  27 (3)  295-301. PubMed ID: 24685550
  33. A novel porcine model of ventilator-associated pneumonia caused by oropharyngeal challenge with Pseudomonas aeruginosa. Li Bassi G Rigol M Marti JD Saucedo L Ranzani OT Roca I Cabanas M Muñoz L Giunta V Luque N Rinaudo M Esperatti M Fernandez-Barat L Ferrer M Vila J Ramirez J Torres A . Anesthesiology  2014 May  120 (5)  1205-15. PubMed ID: 24618700
  34. The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study. Wiemken TL Carrico RM Klein SL Jonsson CB Peyrani P Kelley RR Aliberti S Blasi F Fernandez-Gonzalez R Lopardo G Ramirez JA CAPO Investigators. . Vaccine  2014 Apr 17  32 (19)  2198-203. PubMed ID: 24613522
  35. Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis. Aliberti S Brambilla AM Chalmers JD Cilloniz C Ramirez J Bignamini A Prina E Polverino E Tarsia P Pesci A Torres A Blasi F Cosentini R . Respiratory research  2014 Mar 4  15 ()  27. PubMed ID: 24593040
  36. Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia. Fernandez-Botran R Uriarte SM Arnold FW Rodriguez-Hernandez L Rane MJ Peyrani P Wiemken T Kelley R Uppatla S Cavallazzi R Blasi F Morlacchi L Aliberti S Jonsson C Ramirez JA Bordon J . Inflammation  2014 Aug  37 (4)  1158-66. PubMed ID: 24557760
  37. A worldwide perspective of nursing home-acquired pneumonia compared with community-acquired pneumonia. Liapikou A Polverino E Cilloniz C Peyrani P Ramirez J Menendez R Torres A Community-Acquired Pneumonia Organization (CAPO) Investigators. . Respiratory care  2014 Jul  59 (7)  1078-85. PubMed ID: 24194575
  38. Absence of gender-based differences in outcome of patients with hospital-acquired pneumonia. Caceres F Welch VL Kett DH Scerpella EG Peyrani P Ford KD Ramirez JA Impact-Hap Study Group. . Journal of women's health (2002)  2013 Dec  22 (12)  1069-75. PubMed ID: 24128006
  39. Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia. Cavallazzi R Wiemken T Christensen D Peyrani P Blasi F Levy G Aliberti S Kelley R Ramirez J Community-Acquired Pneumonia Organization (CAPO) Investigators. . The European respiratory journal  2014 Jan  43 (1)  178-84. PubMed ID: 23794467
  40. Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Arnold FW Wiemken TL Peyrani P Ramirez JA Brock GN CAPO authors. . Respiratory medicine  2013 Jul  107 (7)  1101-11. PubMed ID: 23660396
  41. Cytokines and neutrophils responses in influenza pneumonia. Bordon JM Uriarte S Arnold FW Fernandez-Botran R Rane M Peyrani P Cavallazzi R Saad M Ramirez J . Infection  2013 Oct  41 (5)  1021-4. PubMed ID: 23589279
  42. Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneumonia rather than a predictor of outcomes. Bordon J Aliberti S Duvvuri P Wiemken T Peyrani P Natividad I Caceres-Lara A Delapenha R Blasi F Ramirez J . International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases  2013 May  17 (5)  e293-8. PubMed ID: 23507237
  43. Phenotypic differences in virulence and immune response in closely related clinical isolates of influenza A 2009 H1N1 pandemic viruses in mice. Camp JV Chu YK Chung DH McAllister RC Adcock RS Gerlach RL Wiemken TL Peyrani P Ramirez JA Summersgill JT Jonsson CB . PloS one  2013  8 (2)  e56602. PubMed ID: 23441208
  44. What is the association of cardiovascular events with clinical failure in patients with community-acquired pneumonia? Peyrani P Ramirez J . Infectious disease clinics of North America  2013 Mar  27 (1)  205-10. PubMed ID: 23398875
  45. Clinical scoring tools: which is best to predict clinical response and long-term outcomes? Wiemken T Kelley R Ramirez J . Infectious disease clinics of North America  2013 Mar  27 (1)  33-48. PubMed ID: 23398864
  46. Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA. Pasquale TR Jabrocki B Salstrom SJ Wiemken TL Peyrani P Haque NZ Scerpella EG Ford KD Zervos MJ Ramirez JA File TM Jr IMPACT-HAP Study Group. . International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases  2013 Jun  17 (6)  e398-403. PubMed ID: 23375542
  47. Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia. Ramirez J Dartois N Gandjini H Yan JL Korth-Bradley J McGovern PC . Antimicrobial agents and chemotherapy  2013 Apr  57 (4)  1756-62. PubMed ID: 23357775
  48. Clinical stability and switch therapy in hospitalised patients with community-acquired pneumonia: are we there yet? Ramirez JA . The European respiratory journal  2013 Jan  41 (1)  5-6. PubMed ID: 23277515
  49. Incidence of respiratory viruses in patients with community-acquired pneumonia admitted to the intensive care unit: results from the Severe Influenza Pneumonia Surveillance (SIPS) project. Wiemken T Peyrani P Bryant K Kelley RR Summersgill J Arnold F Carrico R McKinney WP Jonsson C Carrico K Ramirez J . European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology  2013 May  32 (5)  705-10. PubMed ID: 23274861
  50. Criteria for clinical stability in hospitalised patients with community-acquired pneumonia. Aliberti S Zanaboni AM Wiemken T Nahas A Uppatla S Morlacchi LC Peyrani P Blasi F Ramirez J . The European respiratory journal  2013 Sep  42 (3)  742-9. PubMed ID: 23143544
  51. Empiric therapy directed against MRSA in patients admitted to the intensive care unit does not improve outcomes in community-acquired pneumonia. Griffin AT Peyrani P Wiemken TL Ramirez JA Arnold FW . Infection  2013 Apr  41 (2)  517-23. PubMed ID: 23132663
  52. A three-step critical pathway for community-acquired pneumonia reduces duration of hospital stay and intravenous antibiotic use by 2 days. Peyrani P . Evidence-based nursing  2013 Apr  16 (2)  48-9. PubMed ID: 23100261
  53. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. Bordon J Aliberti S Fernandez-Botran R Uriarte SM Rane MJ Duvvuri P Peyrani P Morlacchi LC Blasi F Ramirez JA . International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases  2013 Feb  17 (2)  e76-83. PubMed ID: 23069683
  54. Outcomes in females hospitalised with community-acquired pneumonia are worse than in males. Arnold FW Wiemken TL Peyrani P Mirsaeidi M Ramirez JA Community Acquired Pneumonia Organization (CAPO) Study Group. . The European respiratory journal  2013 May  41 (5)  1135-40. PubMed ID: 22835618
  55. Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacin. Ramirez JA Cooper AC Wiemken T Gardiner D Babinchak T 308 Study Group. . BMC infectious diseases  2012 Jul 19  12 ()  159. PubMed ID: 22812672
  56. Global changes in the epidemiology of community-acquired pneumonia. Wiemken TL Peyrani P Ramirez JA . Seminars in respiratory and critical care medicine  2012 Jun  33 (3)  213-9. PubMed ID: 22718207
  57. Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus. Haque NZ Arshad S Peyrani P Ford KD Perri MB Jacobsen G Reyes K Scerpella EG Ramirez JA Zervos MJ . Journal of clinical microbiology  2012 May  50 (5)  1640-4. PubMed ID: 22337980
  58. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Cano EL Haque NZ Welch VL Cely CM Peyrani P Scerpella EG Ford KD Zervos MJ Ramirez JA Kett DH Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Study Group. . Clinical therapeutics  2012 Jan  34 (1)  149-57. PubMed ID: 22284995
  59. How to handle mortality when investigating length of hospital stay and time to clinical stability. Brock GN Barnes C Ramirez JA Myers J . BMC medical research methodology  2011 Oct 26  11 ()  144. PubMed ID: 22029846
  60. CD4+ cell counts and HIV-RNA levels do not predict outcomes of community-acquired pneumonia in hospitalized HIV-infected patients. Bordon J Kapoor R Martinez C Portela D Duvvuri P Klochko A Ayesu K Peyrani P Cillóniz C Wiemken T Parra A Torres A Rello J Ramirez J . International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases  2011 Dec  15 (12)  e822-7. PubMed ID: 21885316
  61. Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene. Peyrani P Allen M Wiemken TL Haque NZ Zervos MJ Ford KD Scerpella EG Mangino JE Kett DH Ramirez JA IMPACT-HAP Study Group. . Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  2011 Oct  53 (8)  766-71. PubMed ID: 21880581
  62. The use of large databases to study pneumonia: what is their value? Wiemken T Peyrani P Arnold FW Ramirez J . Clinics in chest medicine  2011 Sep  32 (3)  481-9. PubMed ID: 21867817
  63. Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia. Aliberti S Ramirez J Cosentini R Brambilla AM Zanaboni AM Rossetti V Tarsia P Peyrani P Piffer F Blasi F . Respiratory medicine  2011 Nov  105 (11)  1732-8. PubMed ID: 21821405
  64. [Recurrent respiratory infections, pneumonia and pulmonary interstitial infiltrates in a 81 year old man]. Molina M Sánchez M Ramírez J . Medicina clinica  2011 Sep 17  137 (7)  311-6. PubMed ID: 21636102
  65. Computed tomography measurements of parapneumonic effusion indicative of thoracentesis. Moffett BK Panchabhai TS Anaya E Nakamatsu R Arnold FW Peyrani P Wiemken T Guardiola J Ramirez JA . The European respiratory journal  2011 Dec  38 (6)  1406-11. PubMed ID: 21622586
  66. ACR Appropriateness Criteria® acute respiratory illness in immunocompetent patients. Kirsch J Ramirez J Mohammed TL Amorosa JK Brown K Dyer DS Ginsburg ME Heitkamp DE Jeudy J Macmahon H Ravenel JG Saleh AG Shah RD . Journal of thoracic imaging  2011 May  26 (2)  W42-4. PubMed ID: 21508726
  67. Changing needs of community-acquired pneumonia. Ramirez JA Anzueto AR . The Journal of antimicrobial chemotherapy  2011 Apr  66 Suppl 3 ()  iii3-9. PubMed ID: 21482567
  68. Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. Riquelme R Jiménez P Videla AJ Lopez H Chalmers J Singanayagam A Riquelme M Peyrani P Wiemken T Arbo G Benchetrit G Rioseco ML Ayesu K Klotchko A Marzoratti L Raya M Figueroa S Saavedra F Pryluka D Inzunza C Torres A Alvare P Fernandez P Barros M Gomez Y Contreras C Rello J Bordon J Feldman C Arnold F Nakamatsu R Riquelme J Blasi F Aliberti S Cosentini R Lopardo G Gnoni M Welte T Saad M Guardiola J Ramirez J . The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  2011 Apr  15 (4)  542-6. PubMed ID: 21396216
  69. Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia. Aliberti S Peyrani P Filardo G Mirsaeidi M Amir A Blasi F Ramirez JA . Chest  2011 Aug  140 (2)  482-488. PubMed ID: 21330383
  70. Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study. Mangino JE Peyrani P Ford KD Kett DH Zervos MJ Welch VL Scerpella EG Ramirez JA IMPACT-HAP Study Group. . Critical care (London, England)  2011  15 (1)  R38. PubMed ID: 21266065
  71. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Kett DH Cano E Quartin AA Mangino JE Zervos MJ Peyrani P Cely CM Ford KD Scerpella EG Ramirez JA Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators. . The Lancet. Infectious diseases  2011 Mar  11 (3)  181-9. PubMed ID: 21256086
  72. Ventilator-associated pneumonia in critically ill stroke patients: frequency, risk factors, and outcomes. Kasuya Y Hargett JL Lenhardt R Heine MF Doufas AG Remmel KS Ramirez JA Akça O . Journal of critical care  2011 Jun  26 (3)  273-9. PubMed ID: 21106334
  73. Clinical and economic burden of pneumonia among adults in Latin America. Isturiz RE Luna CM Ramirez J . International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases  2010 Oct  14 (10)  e852-6. PubMed ID: 20615741
  74. Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Arnold FW Brock GN Peyrani P Rodríguez EL Díaz AA Rossi P Ramirez JA CAPO authors. . Respiratory medicine  2010 Nov  104 (11)  1736-43. PubMed ID: 20576417
  75. Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia. Haque NZ Zuniga LC Peyrani P Reyes K Lamerato L Moore CL Patel S Allen M Peterson E Wiemken T Cano E Mangino JE Kett DH Ramirez JA Zervos MJ Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators. . Chest  2010 Dec  138 (6)  1356-62. PubMed ID: 20558550
  76. Decrease in long-term survival for hospitalized patients with community-acquired pneumonia. Bordon J Wiemken T Peyrani P Paz ML Gnoni M Cabral P Venero Mdel C Ramirez J CAPO Study Group. . Chest  2010 Aug  138 (2)  279-83. PubMed ID: 20382718
  77. An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets. Martínez-Olondris P Sibila O Agustí C Rigol M Soy D Esquinas C Piñer R Luque N Guerrero L Quera MÁ Marco F de la Bellacasa JP Ramirez J Torres A . The European respiratory journal  2010 Oct  36 (4)  901-6. PubMed ID: 20351024
  78. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study. Griffin AT Peyrani P Wiemken T Arnold F . The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  2010 Apr  14 (4)  495-9. PubMed ID: 20202309
  79. Characteristics of hospitalised patients with 2009 H1N1 influenza in Chile. Riquelme R Riquelme M Rioseco ML Inzunza C Gomez Y Contreras C Riquelme J Peyrani P Wiemken T Ramirez J . The European respiratory journal  2010 Oct  36 (4)  864-9. PubMed ID: 20185421
  80. Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia. Aliberti S Blasi F Zanaboni AM Peyrani P Tarsia P Gaito S Ramirez JA . The European respiratory journal  2010 Jul  36 (1)  128-34. PubMed ID: 19926738
  81. The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia. Aliberti S Brock GN Peyrani P Blasi F Ramirez JA Community-Acquired Pneumonia Organization. . The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  2009 Dec  13 (12)  1550-6. PubMed ID: 19919775
  82. Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Mirsaeidi M Peyrani P Aliberti S Filardo G Bordon J Blasi F Ramirez JA . Chest  2010 Feb  137 (2)  416-20. PubMed ID: 19837825
  83. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arnold FW LaJoie AS Brock GN Peyrani P Rello J Menéndez R Lopardo G Torres A Rossi P Ramirez JA Community-Acquired Pneumonia Organization (CAPO) Investigators. . Archives of internal medicine  2009 Sep 14  169 (16)  1515-24. PubMed ID: 19752410
  84. Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia. Malinis M Myers J Bordon J Peyrani P Kapoor R Nakamatzu R Lopardo G Torres A Feldman C Allen M Arnold F Ramirez J . International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases  2010 Jan  14 (1)  e22-7. PubMed ID: 19586789
  85. The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia. Aliberti S Myers JA Peyrani P Blasi F Menendez R Rossi P Casentini R Lopardo G de Vedia L Ramirez JA . Revista portuguesa de pneumologia  2009 Jul-Aug  15 (4)  736-9. PubMed ID: 25965920
  86. Predicting mortality in patients with ventilator-associated pneumonia: The APACHE II score versus the new IBMP-10 score. Mirsaeidi M Peyrani P Ramirez JA Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators. . Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  2009 Jul 1  49 (1)  72-7. PubMed ID: 19480582
  87. [Diffuse interstitial lung disease related to peribronchiolar metaplasia]. Cano-Jiménez E Molina-Molina M Ramírez J Sánchez M Aliaga JL Xaubet A . Archivos de bronconeumologia  2009 Jan  45 (1)  57-9. PubMed ID: 19186300
  88. RSV infection in the adult population. Ramirez JA . Managed care (Langhorne, Pa.)  2008 Nov  17 (11 Suppl 12)  13-5, discussion 18-9. PubMed ID: 19097558
  89. The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia. Aliberti S Myers JA Peyrani P Blasi F Menendez R Rossi P Cosentini R Lopardo G de Vedia L Ramirez JA . The European respiratory journal  2009 Jan  33 (1)  142-7. PubMed ID: 18829671
  90. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Aliberti S Amir A Peyrani P Mirsaeidi M Allen M Moffett BK Myers J Shaib F Cirino M Bordon J Blasi F Ramirez JA . Chest  2008 Nov  134 (5)  955-962. PubMed ID: 18583514
  91. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Charles PG Wolfe R Whitby M Fine MJ Fuller AJ Stirling R Wright AA Ramirez JA Christiansen KJ Waterer GW Pierce RJ Armstrong JG Korman TM Holmes P Obrosky DS Peyrani P Johnson B Hooy M Australian Community-Acquired Pneumonia Study Collaboration. Grayson ML . Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  2008 Aug 1  47 (3)  375-84. PubMed ID: 18558884
  92. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Ramirez J Aliberti S Mirsaeidi M Peyrani P Filardo G Amir A Moffett B Gordon J Blasi F Bordon J . Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  2008 Jul 15  47 (2)  182-7. PubMed ID: 18533841
  93. [Adherence with national guidelines in hospitalized patients with community-acquired pneumonia. Results of CAPO study in Argentina]. Christensen D Luna CM Martínez J Rodriguez E Marzoratti L Gonzalez J Videla AJ De Vedia L Corral J Benchetrit G Rodriguez M Victorio C Lopardo G Peyrani P Ramirez J . Medicina  2007  67 (6 Pt 2)  709-13. PubMed ID: 18422063
  94. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Bordón J Peyrani P Brock GN Blasi F Rello J File T Ramirez J CAPO Study Group. . Chest  2008 Mar  133 (3)  618-24. PubMed ID: 18198264
  95. Fostering international multicenter collaborative research: the CAPO Project. Ramirez JA . The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  2007 Oct  11 (10)  1062-5. PubMed ID: 17945061
  96. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Arnold FW Summersgill JT Lajoie AS Peyrani P Marrie TJ Rossi P Blasi F Fernandez P File TM Jr Rello J Menendez R Marzoratti L Luna CM Ramirez JA Community-Acquired Pneumonia Organization (CAPO) Investigators. . American journal of respiratory and critical care medicine  2007 May 15  175 (10)  1086-93. PubMed ID: 17332485
  97. Antibiotic therapy of hospitalized patients with community-acquired pneumonia: an international perspective from the CAPO Cohort Study. Peyrani P Christensen D LaJoie AS Nakamatsu R Arnold F Schulz P Toala I Ramirez A Lobo S Johnson B Chesnut D Richmond B De La Cruz R Carrico R Ramirez J Community-Acquired Pneumonia Organization Investigators. . The Journal of the Kentucky Medical Association  2006 Nov  104 (11)  513-7. PubMed ID: 17175853
  98. [Airway-centered interstitial fibrosis related to exposure to fumes from cleaning products]. Serrano M Molina-Molina M Ramírez J Sánchez M Xaubet A . Archivos de bronconeumologia  2006 Oct  42 (10)  557-9. PubMed ID: 17067524
  99. Incidence and risk factors for ventilator-associated pneumonia in a developing country: where is the difference? Jaimes F De La Rosa G Gómez E Múnera P Ramírez J Castrillón S . Respiratory medicine  2007 Apr  101 (4)  762-7. PubMed ID: 17027247
  100. The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia. Arnold F LaJoie A Marrie T Rossi P Blasi F Luna C Fernandez P Porras J Weiss K Feldman C Rodríguez E Levy G Arteta F Roig J Rello J Ramirez J Community-Acquired Pneumonia Organization. . The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  2006 Jul  10 (7)  739-43. PubMed ID: 16848334

© 2014-2017 Clinical Research Support Program (CRSP). All rights reserved.